Relevant bibliographies by topics / Osteoporsis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Osteoporsis'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Osteoporsis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Osteoporsis"

1

Byun, Young Soon, and Ok Soo Kim. "Life Style and Self-efficacy in Osteoporsis Women." Journal of Korean Academy of Nursing 29, no. 3 (1999): 530. http://dx.doi.org/10.4040/jkan.1999.29.3.530.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kruger, Marlena C., and David F. Horrobin. "Calcium metabolism, osteoporsis and essential fatty acids: A review." Progress in Lipid Research 36, no. 2-3 (September 1997): 131–51. http://dx.doi.org/10.1016/s0163-7827(97)00007-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Narita, Syugo, Masanori Nakashima, and Yasushi Yamashita. "Bone mineral density by digital image processing method in patients with osteoporsis." Orthopedics & Traumatology 39, no. 2 (1990): 430–32. http://dx.doi.org/10.5035/nishiseisai.39.430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

ul Haq, N., M. Tahir, Q. Iqbal, A. Naseem, S. Mohammd, N. Ahmed, and S. A. Azhar. "Assessment of Osteoporsis Knowledge And Perception Among Female University Students In Quetta, Pakistan." Value in Health 18, no. 3 (May 2015): A169. http://dx.doi.org/10.1016/j.jval.2015.03.976.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pinho, Mara Suzana. "Osteoporos e Osteoporosis." Revista Brasileira de Reumatologia 43, no. 3 (June 2003): 185–88. http://dx.doi.org/10.1590/s0482-50042003000300011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sánchez Márquez, Pedro, and Carlos Arturo Révérend Lizcano. "Factores de diferenciación génica y su futuro en el tratamiento de la osteoporosis: de la adipogénesis a la osteoblastogénesis, ¿del mismo modo y en sentido contrario?" Revista Colombiana de Endocrinología, Diabetes & Metabolismo 5, no. 4 (November 20, 2018): 21–25. http://dx.doi.org/10.53853/encr.5.4.450.

Full text
Abstract:
El presente artículo tiene como objetivo presentar de forma resumida los diferentes factores que están involucrados en la diferenciación y el mantenimiento del fenotipo óseo, en contraste con los factores adipogénicos, cuya expresión determina procesos de diferenciación mutuamente excluyentes. Por otro lado, se propone el posible uso terapéutico para distintas patologías óseas como la osteoporosis. Los datos fueron obtenidos de estudios clínicos aleatorizados y de revisión, en idioma español e inglés, de los últimos 15 años, que incluyeran los términos Mesh: Osteoporosis; Osteoporoses; Osteoporosis, Post-Traumatic; Osteoporosis, Senile; Osteoporosis, Age-Related; Bone Loss, Age-Related; Factors, Transcription; Transcription Factor; Adipogeneses; Bone Formation; Osteoclastogenesis; Endochondral Ossification; Endochondral Ossifications; Ossification, Endochondral; Ossification, Physiological; Ossification, Physiologic.
APA, Harvard, Vancouver, ISO, and other styles
7

Baccichetti, A., P. L. Nguyen-Thi, A. Blum, D. Mainard, F. Sirveaux, L. Nace, A. Valance, et al. "SAT0459 EVALUATION OF THE PREVALENCE AND THE MANAGEMENT OF OSTEOPOROTIC FRACTURES IN PATIENTS HOSPITALIZED AT NANCY UNIVERSITY HOSPITAL (FRANCE) IN 2017." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1187.1–1187. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3366.

Full text
Abstract:
Background:Osteoporotic fractures are a major public health concern because of their consequences in morbidity, costs and mortality. In the meantime, historically postfracture osteoporosis medication use rates have been poor.Objectives:The aim is to analyze the management of osteoporosis in patients hospitalized for osteoporotic fractures (OF) at Nancy University Hospital (France) in 2017.Methods:Total number of hospitalized patients and hospital stays were extracted by the Department of Medical Information (DIM) which selected departments with at least forty hospitalizations with Medical Unit Summary related to a diagnosis of fracture or osteoporosis. Hospitalizations not concerned by a recent OF were excluded. Data on fractures, patient characteristics, risk factors for OF and fall, management of osteoporosis, discharge status, stay duration, were studied from patient medical records. Prevalence of OF stays, management of osteoporosis and factors associated with duration of stay were analyzed.Results:Out of a total of 153,840 hospitalizations, 918 hospitalizations (844 patients, mean age 74.5 years ± 13.6, 74.5% women) concern an OF. The prevalence of hospitalizations for OF was 0.6% of total hospitalizations and 17.9% of total hospitalizations for fractures. Among the 844 patients, 85.7% had a severe fracture (vertebral fracture: 56.2%, hip fracture: 24.1%), 16.5% had a non-severe fracture, and 8.5% had a fracture cascade in the year. At discharge from hospital, 11.7% of patients received a specific treatment for osteoporosis. Longer stay duration was associated with age, severe fractures, Groll index and discharge status.Conclusion:Nearly one hospitalized fracture in five is osteoporotic, while only one in ten patients is treated for osteoporosis. Stay duration increased with age and comorbidities. This encourages the development of early prevention, screening and treatment strategies for osteoporosis.References:[1]Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.[2]Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006 Oct 19;17(12):1726–33.[3]Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD. Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon. Semin Arthritis Rheum. 2006 Apr;35(5):293–305.Disclosure of Interests:None declared
APA, Harvard, Vancouver, ISO, and other styles
8

ASLAN, Gulpinar, and Dilek KILIC. "OSTEOPOROSIS HEALTH BELIEF, KNOWLEDGE LEVEL AND RISK FACTORS IN INDIVIDUALS WHOSE BONE MINERAL DENSITY WAS REQUIRED." Belitung Nursing Journal 3, no. 3 (June 7, 2017): 162–73. http://dx.doi.org/10.33546/bnj.67.

Full text
Abstract:
Aim: This descriptive-relational study aims to identify osteoporosıs health belief, knowledge level and risk factors in individuals whose bone mineral density was required.Method: Target population of the study was 110 men and 126 women aged 35 and over, who applied to Atatürk University Aziziye - Yakutiye Research Hospital Nuclear Medicine Center Bone Densitometer Unit between January 2010 and October 2010. No sampling was performed, the whole target population was involved in the study. Data were collected through the Personal Information Form that included socio-demographic features, The Osteoporosis Health Belief Scale, the Osteoporosis Self-Efficacy Scale and the Osteoporosis Knowledge Test.Results: The Osteoporosis Health Belief score of the participants was 139.99±14.79, Osteoporosis Knowledge score was 10.06±4.30, and Osteoporosis Self-Efficacy score was 742.00±213.44. Among Osteoporosis health beliefs, women’s Susceptibility, Seriousness, Barriers of Exercise, and Barriers of Calcium mean scores were found to be higher than those of men (p<0.001). Men’s Osteoporosis Self-Efficacy scale and sub-dimensions mean scores were found to be higher in comparison to women (p<0.001). DEXA analysis results show that 57.1% of the women and 27.3% of the men were diagnosed with osteoporosis. Conclusion: According to the Logistic regression analysis that aimed to identify the risk factors having roles in Osteoporosis diagnosis, the affecting risk factors were gender, age, and medicine use. As for women, logistic regression analysis showed that the risk factors were education level – being illiterate, medicine use, osteoporosis story in family, and 4 or more deliveries.
APA, Harvard, Vancouver, ISO, and other styles
9

De Martinis, Massimo, Lia Ginaldi, Maria Maddalena Sirufo, Giovanni Pioggia, Gioacchino Calapai, Sebastiano Gangemi, and Carmen Mannucci. "Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review." Medicina 56, no. 3 (March 19, 2020): 138. http://dx.doi.org/10.3390/medicina56030138.

Full text
Abstract:
Alarmins are endogenous mediators released by cells following insults or cell death to alert the host’s innate immune system of a situation of danger or harm. Many of these, such as high-mobility group box-1 and 2 (HMGB1, HMGB2) and S100 (calgranulin proteins), act through RAGE (receptor for advanced glycation end products), whereas the IL-1 and IL-33 cytokines bind the IL-1 receptors type I and II, and the cellular receptor ST2, respectively. The alarmin family and their signal pathways share many similarities of cellular and tissue localization, functions, and involvement in various physiological processes and inflammatory diseases including osteoporosis. The aim of the review was to evaluate the role of alarmins in osteoporosis. A bibliographic search of the published scientific literature regarding the role of alarmins in osteoporosis was organized independently by two researchers in the following scientific databases: Pubmed, Scopus, and Web of Science. The keywords used were combined as follows: “alarmins and osteoporosis”, “RAGE and osteoporosis”, “HMGB1 and osteoporosis”, “IL-1 and osteoporosis”, “IL 33 and osteopororsis”, “S100s protein and osteoporosis”. The information was summarized and organized in the present review. We highlight the emerging roles of alarmins in various bone remodeling processes involved in the onset and development of osteoporosis, as well as their potential role as biomarkers of osteoporosis severity and progression. Findings of the research suggest a potential use of alarmins as pharmacological targets in future therapeutic strategies aimed at preventing bone loss and fragility fractures induced by aging and inflammatory diseases.
APA, Harvard, Vancouver, ISO, and other styles
10

Suarni, Leny. "FAKTOR-FAKTOR PENYEBAB TERJADINYA PENYAKIT OSTEOPOROSIS PADA LANSIA DI UPT PELAYANAN SOSIAL LANJUT USIA DI WILAYAH BINJAI TAHUN 2017." Jurnal Riset Hesti Medan Akper Kesdam I/BB Medan 2, no. 1 (June 1, 2017): 60. http://dx.doi.org/10.34008/jurhesti.v2i1.61.

Full text
Abstract:
Osteoporosis is a disease that attacks the bone where the bone becomes brittle (flagella) and is easily broken and fractured. Many of the factors that cause Osteopororsis are one of them is calcium deficiency, especially in childhood to adolescence. By looking at the conditions above, the writer wants to do a research that aims to find out the Factors Causing Osteoporosis in the Elderly in the 2017 Binjai Elderly Service Unit. This research is descriptive with a cross sectional design carried out for the elderly with 25 people. This data collection is done by questionnaire. The results of this study indicate that the factors that cause osteoporosis are calcium deficiency factors as many as 18 people (72%), drug factors as many as 20 people (80%), smoking factors and consuming alcohol as many as 10 people (40%), factors lack of exercise as many as 19 people (76%), and disease factors as many as 15 people (60%). So, it can be concluded that the most dominant cause of osteoporosis in the elderly in the UPT for Elderly Social Services in the Binjai Region in 2017 is 80% Medicines. Therefore, it is expected that the elderly will consume less drugs that can cause Osteoporosis.Keywords: Osteoporosis, Causes of Osteoporosis, Elderly
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Osteoporsis"

1

Zochling, Jane Margaret. "The Epidemiology of Osteoporosis in the Frail Institutionalized Elderly." University of Sydney. Department of Rheumatology, 2004. http://hdl.handle.net/2123/637.

Full text
Abstract:
As our population ages, the proportion of frail elderly people requiring assisted accommodation in aged care facilities is increasing. This population is at high risk of falls and fractures, which bring significant morbidity and mortality. The prevalence of osteoporosis also increases with age, but there have been few studies of bone density in residents of hostels and nursing homes. This thesis looked at the prevalence of osteoporosis and falls in elderly people in residential care, to define the size of the problem and identify risk factors for low bone density and falling, with particular reference to vitamin D levels. Two thousand and five men and women aged between 65 and 104 years were enrolled in the Falls and Fracture Risk in the Elderly Epidemiology (FREE) study between 1999 and 2003. The key findings from analysis of this population were firstly, that quantitative ultrasound (QUS) measures were higher in men than women independent of age, and that in men there was no significant decline in either BUA or VOS, but in women BUA declined by over 3% per decade and VOS by 1% per decade. Both ultrasound machines used in the study were shown to be reliable, with precision unaffected by advanced age. QUS was found to be sensitive to longitudinal change even in this frail elderly cohort. Vitamin D deficiency was found in the majority of elderly aged care facility residents but supplementation conferred higher serum 25-OH-vitamin D levels. Vitamin D levels were not shown to be related to BUA, VOS or the risk of falling in this population. Serum parathyroid hormone might be important in determining future falls risk. In summary, the results of this thesis give an important insight into the prevalence of osteoporosis and falls in the frail elderly, and how these might be predicted. Future study of prospective fracture rates in this group will then be able to assess relative risk factors for osteoporotic fracture, and identify those individuals who might benefit from directed fracture prevention strategies.
APA, Harvard, Vancouver, ISO, and other styles
2

Zochling, Jane Margaret. "The Epidemiology of Osteoporosis in the Frail Institutionalized Elderly." Thesis, The University of Sydney, 2003. http://hdl.handle.net/2123/637.

Full text
Abstract:
As our population ages, the proportion of frail elderly people requiring assisted accommodation in aged care facilities is increasing. This population is at high risk of falls and fractures, which bring significant morbidity and mortality. The prevalence of osteoporosis also increases with age, but there have been few studies of bone density in residents of hostels and nursing homes. This thesis looked at the prevalence of osteoporosis and falls in elderly people in residential care, to define the size of the problem and identify risk factors for low bone density and falling, with particular reference to vitamin D levels. Two thousand and five men and women aged between 65 and 104 years were enrolled in the Falls and Fracture Risk in the Elderly Epidemiology (FREE) study between 1999 and 2003. The key findings from analysis of this population were firstly, that quantitative ultrasound (QUS) measures were higher in men than women independent of age, and that in men there was no significant decline in either BUA or VOS, but in women BUA declined by over 3% per decade and VOS by 1% per decade. Both ultrasound machines used in the study were shown to be reliable, with precision unaffected by advanced age. QUS was found to be sensitive to longitudinal change even in this frail elderly cohort. Vitamin D deficiency was found in the majority of elderly aged care facility residents but supplementation conferred higher serum 25-OH-vitamin D levels. Vitamin D levels were not shown to be related to BUA, VOS or the risk of falling in this population. Serum parathyroid hormone might be important in determining future falls risk. In summary, the results of this thesis give an important insight into the prevalence of osteoporosis and falls in the frail elderly, and how these might be predicted. Future study of prospective fracture rates in this group will then be able to assess relative risk factors for osteoporotic fracture, and identify those individuals who might benefit from directed fracture prevention strategies.
APA, Harvard, Vancouver, ISO, and other styles
3

Magallares, López Berta Paula. "Estudio de fragilidad ósea en población pediátrica con factores de riesgo." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/667390.

Full text
Abstract:
La presente tesis doctoral aborda el problema de la Baja Masa Ósea para la edad cronológica (BMOec) y la Osteoporosis infantil (OPi), situaciones que pueden ser silentes y que requieren de una investigación activa para llegar a su diagnóstico en edad pediátrica. El objetivo principal de esta tesis es estimar la prevalencia de dichas enfermedades en los pacientes con riesgo de presentarlas, así como evaluar las características densitométricas de los mismos, tanto la cantidad ósea mediante Densidad Mineral Ósea, como la calidad ósea mediante Trabecular Bone Score. Los objetivos secundarios han sido describir las características clínicas de esta población y comparar los hallazgos densitométricos con los de población sana sin factores de riesgo. Se incluyeron 103 pacientes con edades comprendidas entre los 2 y los 20 años de edad. Todos ellos con al menos un factor de riesgo: entre los más prevalentes la presencia de un diagnóstico potencialmente osteopenizante y la ingesta inadecuada de calcio. Entre el 6 y el 10% de la muestra presentaba BMOec, que variaba según la región de interés estudiada y el ajuste de talla. Cinco sujetos presentaban criterios de OPi por presencia de fracturas vertebrales, en 4 de ellos las fracturas fueron silentes y descubiertas mediante técnicas de imagen. TBS resultó inferior en los sujetos con BMOec medida en cuerpo entero. La DMO de adolescentes y jóvenes fue menor en población con factores de riesgo frente a la población sana de la misma edad y género. TBS fue menor en adolescentes y jóvenes femeninas pero mayor en el resto de grupos estudiados.
This doctoral thesis deals with Low Bone Mass for chronological age (LBMca) and infantile Osteoporosis (iOP), both can be asymptomatic and may require an extra effort to get to their diagnosis in pediatric age. The main objective of this work is to estimate the prevalence of these diseases in patients at risk of presenting them, as well as to evaluate these patient’s densitometric characteristics, both quantity through Bone Mineral Density, and quality through Trabecular Bone Score. Secondary objectives include the description of the clinical characteristics of our sample, as well as the comparison of the densitometric findings with those of healthy peers without risk factors. We included 103 patients aged between 2 and 20 years of age. All of them with at least one risk factor. The presence of a potentially osteopening diagnosis and the inadequate calcium intake that did not reach the daily recommendations were the most prevalent risks factors. Between 6 and 10% of the sample presented LBMca, which varied according to the regions of interest studied and the height adjustment. 5 subjects met iOP criteria for the presence of vertebral fractures. In 4 of them, these fractures were silent and were localized by imaging techniques. TBS was lower in subjects with LBMca measured in the whole body region. Adolescents and young people BMD was lower in the population with risk factors compared to the healthy population of the same age and gender. TBS was lower in adolescents and young women but higher in the rest of the groups.
APA, Harvard, Vancouver, ISO, and other styles
4

Wilson, Aubrie. "Osteoporosis." Online version, 2009. http://www.uwstout.edu/lib/thesis/2009/2009wilsona.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Misner, Scottie. "Osteoporosis." College of Agriculture and Life Sciences, University of Arizona (Tucson, AZ), 2011. http://hdl.handle.net/10150/146661.

Full text
Abstract:
4 pp.
Originally published: 2000
Osteoporosis means "porous bones." it is a condition where the skeleton becomes fragile and results in broken bones under normal use. Osteoporosis is a "silent" condition that happens slowly over years. This publication discusses the symptoms and the risk factors of osteoporosis, as well as how to prevent it.
APA, Harvard, Vancouver, ISO, and other styles
6

Misner, Scottie, and Vanessa A. Farrell. "Osteoporosis." College of Agriculture, University of Arizona (Tucson, AZ), 2017. http://hdl.handle.net/10150/625576.

Full text
Abstract:
4 p. / Originally published: 2000.
Osteoporosis means “porous bones.” It is a condition where the skeleton becomes fragile and results in broken bones under normal use. Osteoporosis is a “silent” condition that happens slowly over years. The rate of bone loss (“resorption”) exceeds the rate of new bone formation (“acretion”). Many times neither a person nor a doctor is aware of weakened bones until one breaks unexpectedly. Originally published: 2000
APA, Harvard, Vancouver, ISO, and other styles
7

Torremadé, Barreda José. "Efectos del tratamiento con testosterona en la densidad mineral ósea y la composición corporal en hombres con Síndrome de Déficit de Testosterona." Doctoral thesis, Universitat de Barcelona, 2016. http://hdl.handle.net/10803/399732.

Full text
Abstract:
ANTECEDENTES DEL TEMA: El síndrome de déficit de testosterona (SDT) es un síndrome clínico y bioquímico asociado a la edad que se caracteriza por unos síntomas sugestivos de déficit de testosterona y una disminución de los niveles de testosterona sérica. La disminución de la densidad mineral ósea, la disminución de la masa magra y el aumento de la masa grasa, asociado a la edad avanzada, puede acentuarse por el efecto concomitante del déficit de testosterona, ya sea por hipogonadismo primario, secundario o por un SDT. Se conocen los efectos beneficiosos en la esfera sexual del tratamiento sustitutivo con testosterona en el SDT pero existe poca evidencia de sus efectos sobre la densidad mineral ósea y la composición corporal. HIPÓTESIS: Cuando los pacientes con SDT son tratados con testosterona deberían producirse aumentos en la densidad mineral ósea y la masa magra, y una disminución de la masa grasa. OBJETIVO: Evaluar la seguridad y eficacia del tratamiento con testosterona y los cambios inducidos en la composición corporal y la densidad mineral ósea del los pacientes con SDT. METODOLOGÍA: Estudio prospectivo, observacional, abierto y no randomizado, realizado en 50 varones de 50-65 años con SDT (Aging Males Symptoms Scale [AMS]>26 y testosterona libre calculada [cFT] < 250 pmol/l) se les administró diariamente 50mg diarios de testosterona en gel durante un año. En el segundo año, los pacientes recibieron 1000mg de undecanoato de testosterona cada 2-3 meses. Se determinaron parámetros clínicos, bioquímicos, testosterona total, proteína transportadora de hormonas sexuales (SHBG), cFT, cambios en AMS, Índice Internacional de Síntomas Prostáticos (IPSS), cambios en la densidad mineral ósea y la composición corporal medidas por dual-x-ray-absorptiometry. RESULTADOS: No se objetivaron cambios clínicamente significativos en parámetros de seguridad clínica y analítica. Se objetivaron incrementos en las concentraciones de testosterona total, cFT y puntuación del AMS a partir de los 3 meses (p<0.001). La densidad mineral ósea mejoró significativamente en la columna vertebral lumbar L2-L4 (2.9 i 4.5%), en el fémur total (0.74 y 3%) y en el trocánter (1.09 y 3.2%) a los 12 y 24 meses respectivamente. La masa magra aumentó en un 2.35% a los 12 meses y en un 4.5% a los 24 meses, pero proporcionalmente el aumento fue superior en los brazos y piernas que en el tronco. La masa grasa disminuyó en un 4.2% a los 12 meses y en un 9.1% a los 24 meses. CONCLUSIONES: El tratamiento sustitutivo con testosterona en hombres con SDT induce mejorías en la densidad mineral ósea de la columna lumbar y la cadera. El tratamiento sustitutivo con testosterona en hombres con SDT induce cambios en la composición corporal, aumentando la masa magra y disminuyendo la masa grasa. El tratamiento sustitutivo con testosterona en hombres con SDT induce asimismo una mejoría sintomática según AMS score y tiene un excelente perfil de seguridad.
OBJECTIVE: We evaluated the safety of testosterone treatment and its efficacy on bone mineral density and body composition in males with testosterone deficiency syndrome (TDS) over 24 months. MATERIAL AND METHODS: This prospective, non-randomized, open-label, long-term follow up study evaluated the safety and efficacy of testosterone treament in men with TDS. 50 males aged 50–65 years with TDS (Aging Males Symptoms Scale [AMS] >26 and calculated free testosterone [cFT] <250 pmol/l) were administered 50mg testosterone gel daily for one year. During the second year, patients received 1000mg of testosterone undecanoate every 2–3 months. Outcome measures were clinical chemistry values and total testosterone; SHBG and cFT, changes in AMS and IPSS; and changes in bone mineral density and body composition measured by dual-energy-x-ray absorptiometry. RESULTS: There were no clinically significant changes in clinical chemistry safety parameters. There were significant improvements in both total and cFT and in AMS scores after 3 months (p<0.001). Bone mineral density improved significantly in L2-L4 (2.90% and 4,5%), total femur (0,74% and 3%) and trochanter (1.09% and 3.2%) at 12 and 24 months. Lean mass increased 2.35% at 12 months and 4.5% at 24 months, but proportionally more muscle mass was gained in arms and legs than in the trunk. Fat mass decreased 4.2% at 12 months and 9.1% at 24 months. CONCLUSIONS: Testosterone treatment in males with TDS leads to significant improvement in lumbar spine and hip BMD. It leads to body changes affecting lean and fat mass with significant improvement in AMS scores.
APA, Harvard, Vancouver, ISO, and other styles
8

Taymouri, Farid. "Reference data for bone material strength index (BMSI) measured by impact microindentation." Doctoral thesis, Universitat Autònoma de Barcelona, 2019. http://hdl.handle.net/10803/666868.

Full text
Abstract:
Objetivo: La microindentación de impacto (MII) es una técnica que permite medir in vivo la resistencia tisular mecánica ósea. Se ha demostrado que la MII proporciona información útil sobre la evaluación de enfermedades esqueléticas, pero se desconoce el efecto que la edad puede ejercer sobre la propiedad ósea medida. El objetivo del estudio es analizar la relación entre la edad y la MII. Material y métodos: El índice de Resistencia Mineral Ósea (BMSi), la variable de medición de MII, se midió en 69 mujeres (mediana de edad: 49 años; rango: 30-81 años) y 19 varones (mediana de edad: 34 años; rango: 24-98 años) sanos. La correlación entre BMSi y la edad se analizó mediante regresión lineal. La asociación entre BMSi y edad se evaluó mediante ANOVA tras ajustar por el índice de masa corporal. El posible efecto de depleción estrogénica postmenopáusica sobre el BMSi se estudió comparando el sub­grupo de mujeres más jóvenes con las más mayores mediante la prueba t de Student. Resultados: Los análisis de regresión lineal mostraron que la BMSi no se correlaciona con la edad en varo­nes (R2=0,0016, p=0,74) ni en mujeres (R'=0,076, p=0,25). Asimismo, el análisis ajustado de ANOVA no demostró asociación entre la BMSi y la edad ni en varones (p=0,78) ni en mujeres (p=0,73). Finalmente, no se encontraron diferencias entre la BMSi entre las mujeres más jóvenes y las mayores (p=0,8). Conclusiones: La resistencia tisular mecánica ósea en individuos sanos es independiente a la edad y a la depleción estrogénica postmenopáusica.
Objective: Impact microindentation (IMI) is a technique that allows the measurement of mechanicalbone tissue resistance in vivo. IMI has proven to provide useful information on the evaluation of skeletal dise­ases, but the effect of age on the bone property that is measured by this technique is unknown. This study aims to analyzethe relationship between age and MIH. Material and methods: Bone Material Strength index (BMSi), IMI's output variable, was measured in 69 healthy women (median age: 49 years, range: 30-81 years) and 19 healthy men (median age: 34 years, range: 24-98 years). The correlation between BMSi and age was analyzed by linear regression. The asso­ciation between BMSi and age was evaluated by ANOVA after adjusting for body mass index. The poten­tial effect of postmenopausal estrogenic depletion on BMSi was studied by comparing the younger vs the older subset of women through a t-student test. Results: Linear regression analysis showed that BMSi was not correlated with age in either men (R'=0.0016, p=0.74) or women (R'=0.076, p=0.25). Similarly, the BMI-adjusted ANOVA model revealed a lack of asso­ciation of BMSi with age in men (p=0.78) and women (p=0.73). Finally, there were not significant diffe­rences on BMSi detected between the younger and the older subset of women (p=0.8). Conclusions: Bone tissue mechanical resistance in healthy individuals is independent of age and postme­nopausal estrogenic depletion.
APA, Harvard, Vancouver, ISO, and other styles
9

Vanhook, Patricia M., Lynne M. Dunphy, T. South, L. Plank, and C. Luskin. "Osteoarthritis and Osteoporosis." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/etsu-works/7411.

Full text
Abstract:
Book Summary: Serves the needs of advanced practice nurses because it’s written by nurse practitioners for nurse practitioners, in collaboration with a physician. Organizes content around the Circle of Caring framework for nursing-based knowledge and holistic care. Explores complementary and alternative treatments for each disorder. Covers the broadest range of human disease and disorders using a systems-based approach, presenting both common complaints and common problems to help students narrow down the possible differentials to the most likely diagnosis. Considers interactions of pharmaceuticals with alternative medications and nutraceuticals. Features coverage of pathophysiology and diagnostic reasoning as well as up-to-date guidance on laboratory and diagnostic tests. Emphasizes evidence-based practice with information on evidence levels and more references to primary studies. Integrates discussions of health policy and primary care throughout the text.
APA, Harvard, Vancouver, ISO, and other styles
10

Hellström, Hans-Olov. "Bone and aluminium /." Uppsala : Acta Universitatis Upsaliensis : Universitetsbiblioteket [distributör], 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Osteoporsis"

1

Osteoporosis: La prevención, el mejor tratamiento. Barcelona: Océano Ámbar, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Woolf, Anthony D. Osteoporosis. London: Martin Dunitz, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Abramovitz, Melissa. Osteoporosis. Detroit: Lucent Books, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Michael, Lewiecki E., ed. Osteoporosis. New York: Oxford University Press, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Osteoporosis. Oxford: Blackwell Science, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1940-, Marcus Robert, ed. Osteoporosis. Boston: Blackwel Scientific Publications, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Osteoporosis. Detroit: Lucent Books, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Orwoll, Eric S., and Michael Bliziotes. Osteoporosis. New Jersey: Humana Press, 2002. http://dx.doi.org/10.1385/1592592783.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sammons, Vivian O. Osteoporosis. Washington, D.C: Science Reference Section, Science and Technology Division, Library of Congress, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

J, Black Alison, and Sandison Rena, eds. Osteoporosis. Oxford: Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Osteoporsis"

1

Blain, Hubert, Tahir Masud, Finbarr C. Martin, and Stefania Maggi. "Osteoporosis." In Practical Issues in Geriatrics, 209–16. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-61997-2_22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Karnes, Jonathan M., and Colleen Watkins. "Osteoporosis." In Orthopedic Surgery Clerkship, 739–41. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-52567-9_152.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Yuksel, Nese, and Theresa L. Charrois. "Osteoporosis." In Patient Assessment in Clinical Pharmacy, 235–43. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Barry, Maurice. "Osteoporosis." In Clinical Practice in Rheumatology, 95–97. London: Springer London, 2003. http://dx.doi.org/10.1007/978-0-85729-430-2_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pignolo, Robert J. "Osteoporosis." In Classic Papers in Geriatric Medicine with Current Commentaries, 95–104. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-428-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Veloski, Colleen. "Osteoporosis." In Women’s Health in Clinical Practice, 47–69. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-469-8_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Miller, Paul D., and Socrates E. Papapoulos. "Osteoporosis." In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 343–44. Ames, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118453926.part5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Baum, Thomas, Dimitrios C. Karampinos, Stefan Ruschke, Hans Liebl, Peter B. Noël, and Jan S. Bauer. "Osteoporosis." In Spinal Imaging and Image Analysis, 67–93. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12508-4_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Annamalai, Aniyizhai. "Osteoporosis." In Medical Management of Psychotropic Side Effects, 289–90. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-51026-2_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bartl, R., and B. Frisch. "Osteoporosis." In Biopsy of Bone in Internal Medicine: An Atlas and Sourcebook, 98–115. Dordrecht: Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-2222-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Osteoporsis"

1

Paoletti, Nicola, Pietro Liò, Emanuela Merelli, and Marco Viceconti. "Osteoporosis." In the 9th International Conference. New York, New York, USA: ACM Press, 2011. http://dx.doi.org/10.1145/2037509.2037536.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shukla, Amit, and Amit Bhattacharya. "Nonlinear Effects of Bone Damping on Human Postural Balance." In ASME 2015 International Design Engineering Technical Conferences and Computers and Information in Engineering Conference. American Society of Mechanical Engineers, 2015. http://dx.doi.org/10.1115/detc2015-46886.

Full text
Abstract:
Osteoporosis is a common disease in women over the age of 50. The detection of this disease is done by an expensive bone mineral density test using dual energy x-ray absorpiometry. Osteoporosis patients are at a high risk of bone fracture under daily living conditions. Previous studies have shown that natural shock absorption capability of human body suffering from osteoporosis is significantly impaired. This study is to develop an understanding of nonlinear effects of osteoporosis on human postural balance via computational models developed to capture changes in the shock absorption capabilities of human musculoskeletal system in osteoporosis patients. This paper uses a previously published, time delayed model of human postural balance by simulating the effect of osteoporosis via changes in damping factor. Numerical studies are presented and results interpreted to capture and highlight the nonlinear effects of osteoporosis on the dynamics postural balance response. This approach, upon further clinical evaluation can result in utilization of human postural balance test and the corresponding non-invasive Bone Shock Absorption test and measurement techniques for detection of osteoporosis.
APA, Harvard, Vancouver, ISO, and other styles
3

Dai, Chao. "Molecular Mechanisms of Osteoporosis: A Road Map for Osteoporosis Therapeutics." In International Conference on Health Big Data and Intelligent Healthcare. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011372900003438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gohil, Vipul P., Paul K. Canavan, and Hamid Nayeb-Hashemi. "Effect of Bone Tumor and Osteoporosis on Mechanical Properties of Bone and Bone Tissue Properties: A Finite Element Study." In ASME 2007 International Mechanical Engineering Congress and Exposition. ASMEDC, 2007. http://dx.doi.org/10.1115/imece2007-42389.

Full text
Abstract:
This research is aimed to study the variations in the biomechanical behavior of bone and bone tissues with osteoporosis and bone tumors. Osteoporosis and bone tumors reduce the mechanical strength of bone, which creates a greater risk of fracture. In the United States alone, ten million individuals, eight million of whom are women, are estimated to already have osteoporosis, and almost 34 million more are estimated to have low bone mass (osteopenia) placing them at increased risk for osteoporosis. World Health Organization defines osteopenia, as a bone density between one and two and a half standard deviations (SD) below the bone density of a normal young adult. (Osteoporosis is defined as 2.5 SD or more below that reference point.). Together, osteoporosis and osteopenia are expected to affect an estimated 52 million women and men age 50 and older by 2010, and 61 million by 2020. The current medical cost of osteoporosis total is nearly about $18 billion in the U.S. each year. There is a dearth of literature that addresses the effects of osteoporosis on bone tissue properties. Furthermore, there are few studies published related to the effect of bone tumors such as Adamantinoma of long bones, Aneurysmal bone cyst, Hemangioma and others on overall behavior of bone. To understand the variations in bio-mechanical properties of internal tissues of bone with osteoporosis and bone tumor, a 2D finite element (FE) model of bone is developed using ANSYS 9.0 ® (ANSYS Inc., Canonsburg, PA). Trabecular bone is modeled using hexagonal and voronoi cellular structure. This finite element model is subjected to change in BVF (bone volume fraction) and bone architecture caused by osteoporosis. The bone tumor is modeled as finer multi-cellular structure and the effects of its size, location, and property variation of tumor on overall bone behavior are studied. Results from this analysis and comparative data are used to determine behavior of bone and its tissue over different stage of osteoporosis and bone tumor. Results indicate that both bone tumor and osteoporosis significantly change the mechanical properties of the bone. The results show that osteoporosis increases the bone tissue stiffness significantly as BVF reduces. Bone tissue stiffness is found to increase by 80 percent with nearly 55 percent reduction of BVF. The results and methods developed in this research can be implemented to monitor variation in bio-mechanical properties of bone up to tissue level during medication or to determine type and time for need of external support such as bracing.
APA, Harvard, Vancouver, ISO, and other styles
5

Dewi, Patria Sari. "Factors Associated with Osteoporosis." In The 5th Intenational Conference on Public Health 2019. Masters Program in Public Health, Universitas Sebelas Maret, 2019. http://dx.doi.org/10.26911/theicph.2019.01.55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ferrari, Serge. "SP0002 HOT: OSTEOPOROSIS @2019." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8475.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Polyakov, Vitaliy, Gleb Kravtsov, J. Polyakova, and B. Zavodovsky. "AB0846 OSTEOPOROSIS IN MEN." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.7330.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Geusens, P. "SP0130 Win session: osteoporosis." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.7267.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

BUCHANAN, JAMES L., and ROBERT P. GILBERT. "MEASURING OSTEOPOROSIS USING ULTRASOUND." In Proceedings of the Sixth International Workshop. WORLD SCIENTIFIC, 2004. http://dx.doi.org/10.1142/9789812702593_0051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vendik, Irina B., Vladimir V. Pleskachev, Viktor Yakovlev, and Svetlana Tamilova. "Microwave diagnostics of osteoporosis." In 2018 IEEE Conference of Russian Young Researchers in Electrical and Electronic Engineering (EIConRus). IEEE, 2018. http://dx.doi.org/10.1109/eiconrus.2018.8317317.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Osteoporsis"

1

su, hui, haipeng xue, ruochong wang, guoqing tan, binghan yan, and zhanwang xu. The efficacy and safety of Tanghuang Jiangu capsule in the treatment osteoporosis: A meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0031.

Full text
Abstract:
Review question / Objective: In order to more systematically and accurately evaluate the clinical efficacy and safety of Tenghuang Jiangu capsule in the treatment of osteoporosis, we used Meta-analysis to provide more reliable evidence-based medical evidence for the treatment of osteoporosis with traditional Chinese medicine. Condition being studied: At present, Tenghuang Jiangu capsule is widely used in clinical practice to treat spinal diseases and improve osteoporosis.Therefore, in order to more systematically and accurately evaluate the clinical efficacy and safety of Tenghuang Jiangu capsule in the treatment of osteoporosis, we used Meta-analysis to provide more reliable evidence-based medical evidence for the treatment of osteoporosis with traditional Chinese medicine.
APA, Harvard, Vancouver, ISO, and other styles
2

Bidwell, Joseph. Maximizing PTH Anabolic Osteoporosis Therapy. Fort Belvoir, VA: Defense Technical Information Center, September 2014. http://dx.doi.org/10.21236/ada610951.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Stern, Paula H. Mechanism of Thyroid Hormone-Induced Osteoporosis. Fort Belvoir, VA: Defense Technical Information Center, October 1998. http://dx.doi.org/10.21236/ada368354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stern, Paula H. Mechanism of Thyroid Hormone-Induced Osteoporosis. Fort Belvoir, VA: Defense Technical Information Center, October 1997. http://dx.doi.org/10.21236/ada340690.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Stern, Paula H. Mechanism of Thyroid Hormone-Induced Osteoporosis. Fort Belvoir, VA: Defense Technical Information Center, October 1999. http://dx.doi.org/10.21236/ada391556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sarafrazi, Neda. Osteoporosis or Low Bone Mass in Older Adults: United States, 2017-2018. National Center for Health Statistics, March 2021. http://dx.doi.org/10.15620/cdc:103477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Xiang, Kemeng, Huiming Hou, and Ming Zhou. The efficacy of Cerus and Cucumis Polypeptide injection combined with Bisphosphonates on postmenopausal women with osteoporosis:A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0067.

Full text
Abstract:
Review question / Objective: The aim of this review is to evaluate the effectiveness of Cerus and Cucumis Polypeptide injection combined with Bisphosphonates for postmenopausal osteoporosis. Condition being studied: Postmenopausal osteoporosis (PMOP) is a disorder of bone metabolism caused by estrogen deficiency in women after menopause, which manifests clinically as pain, spinal deformities and even fragility fractures, affecting the quality of life of patients and possibly shortening their life span. Bisphosphonates are commonly used to control and delay the progression of the disease, improve the patient's symptoms and reduce the incidence of fragility fractures. However, single drugs are still lacking in controlling the progression of the disease, and the combination of drugs is the clinical priority.
APA, Harvard, Vancouver, ISO, and other styles
8

Lanske, Beate. Role of Klotho in Osteoporosis and Renal Osteodystrophy. Fort Belvoir, VA: Defense Technical Information Center, October 2014. http://dx.doi.org/10.21236/ada613419.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kelley, George A. Exercise and Osteoporosis: A Dose-Response Meta-Analysis. Fort Belvoir, VA: Defense Technical Information Center, May 2013. http://dx.doi.org/10.21236/ada580198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Polyakova, Yu V., L. E. Sivordova, E. A. Guryanova, B. V. Zavodovsky, and E. N. Shamitova. Is male osteoporosis a medical or social problem? Academy of Natural Knowledge, 2019. http://dx.doi.org/10.18411/2070-7428-2019-1-28556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Osteoporsis' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography